|
Match
|
Document |
Document Title |
|
|
8173859 |
Epilepsy model animal
An epilepsy model animal (CHRNA4:S284L) developing spontaneous epileptic seizure during sleep, which is a nonhuman animal established by ontogenesis of a totipotent cell into which a polynucleotide...
|
|
|
8173861 |
Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
The present invention discloses a non-human animal model for a hereditary autosomal dominant disease. The non-human animal model expresses at least one phenotype associated with the disease and is...
|
|
|
8148143 |
Method and composition for genetically modifying non-human cells and animals
A vector and its use to generate genetically modified animals and cells is disclosed. One aspect involves a vector that comprises a sperm cell and one or more polynucleotide molecules bound to a...
|
|
|
8134044 |
Transgenic reptiles
A transgenic animal such as a transgenic snake or other reptile that expresses a heterologous expression product is described, along with methods of making the same. In general, the animal...
|
|
|
8101816 |
RGMc modified transgenic animals
The invention provides a new reproducible transgenic mouse model for the study of iron accumulation in the body. In particular, the invention concerns the study of iron overload in an RGMc knockout...
|
|
|
RE42704 |
Production of fibrinogen in transgenic animals
Materials and methods for producing fibrinogen in transgenic non-human mammals are disclosed. DNA segments encoding Aα, Bβ and γ chains of fibrinogen are introduced into the germ line of a no...
|
|
|
8008540 |
Transgenic non-human animal for use in research models for studying Parkinson's disease
The invention relates to a transgenic mouse model with deficient respiratory chain function in dopamine (DA) neurons. By suppressing or deleting the mitochondrial transcription factor A (Tfam) in...
|
|
|
8003847 |
Non-human mutant mammals deficient in Sigma receptors and their applications
The genome of the non-human mutant mammal, deficient in an endogenous Sigma receptor, contains a mutation that comprises a disruption in an endogenous Sigma receptor gene, wherein said gene...
|
|
|
7956238 |
Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes
The present invention relates to a novel promoter and its use in driving expression of foreign genes in transgenic animals (especially pigs). Accordingly, the present invention provides a method...
|
|
|
7947448 |
Use of regulatory sequences for specific, transient expression in neuronal determined cells
The present invention relates to the use of regulatory sequences for mediating specific, early transient expression in proliferative neuronal determined cells. Furthermore, the uses of recombinant...
|
|
|
7943815 |
Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof
The object of the invention is a method for the production of a non-human transgenic mammal by means of which it is possible to monitor in vivo and in all the tissues the state of activation of any...
|
|
|
7868223 |
Method for modifying chromosomes
The present invention relates to a method for producing a modified foreign chromosome(s) or a fragment(s) thereof, which comprises the steps of: (a) preparing a microcell comprising a foreign...
|
|
|
7834237 |
Materials and methods relating to protein aggregation in neurodegenerative disease
Disclosed is a method of inducing or modeling a disease associated with pathological tau protein aggregation. The method can be carried out in vitro and animal models, and may be used to screen for...
|
|
|
7745688 |
Model mouse of Alzheimer's disease expressing FAD APP 716 and use thereof
The present invention provides a non-human model mammal of Alzheimer's disease (AD) containing chimeric amyloid precursor protein (APP) gene capable of producing human amyloid β peptide (Aβ) or a l...
|
|
|
7732659 |
Injecting Drosophila embryos
The present invention provides systems that allow reliable multiplexed transformation of Drosophila embryos. The present invention provides methods and reagents that allow preparation of...
|
|
|
7732658 |
Composition and method for imaging cells
The invention relates to compositions containing a polynucleotide encoding for a reporter gene, a selectable marker and a regulatory element, that provide a method for imaging cells in vivo.
|
|
|
7718846 |
Animal models of long QT syndrome and uses thereof
Provided are animal models of long QT syndrome (LQTS). The animal models are useful, for example, in screening of drugs for adverse effects in subjects with LQTS, in screening candidate...
|
|
|
7709695 |
Transgenic mouse expressing arctic mutation E693G
A transgenic non-human animal expressing at least one transgene including a DNA sequence encoding a heterologous Amyloid Precursor Protein (APP) including at least the Arctic mutation (E693G) and a...
|
|
|
7700825 |
Recombinant constructs and transgenic fluorescent ornamental fish therefrom
The present invention relates to the method and use of reef coral fluorescent proteins in making transgenic red, green and yellow fluorescent zebrafish. Preferably, such fluorescent zebrafish are...
|
|
|
7663019 |
Transgenic snakes and methods of making
A transgenic animal such as a transgenic snake or other reptile that expresses a heterologous expression product is described, along with methods of making the same. In general, the animal...
|
|
|
7663018 |
Tau hyperphosphorylation in transgenic mice expressing the APP double mutation
Animal model involving transgenic manipulation of amyloid precursor protein, useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular...
|
|
|
7659442 |
Method for making homozygous genetic modifications
Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a...
|
|
|
7659443 |
Method of constructing nucleus-implanted egg, parthenogenetic embryo and parthenogenetic mammal
Disclosed is a method for constructing a nucleus-implanted egg, a parthenogenetic embryo and for producing a parthenogenetic mammal each having 2 haploid genome sets originating in mammalian ova,...
|
|
|
7622630 |
Chimeric cancer models
Chimeric nonhuman mammals useful as inducible spontaneous cancer models are disclosed. The nonhuman mammals are obtained by introducing one or more genetically modified embryonic stem (ES) cells...
|
|
|
7608750 |
Nonhuman model animal unresponsive to immunopotentiating synthetic compound
The present invention relates to provide a non-human animal model unresponsive to a synthetic compound wherein a gene function encoding TLR7 that recognizes an immunopotentiating synthetic compound...
|
|
|
7592502 |
Knock-in non-human animal producing human tissue factor
A non-human animal that produces human tissue factor (TF) without substantially producing non-human animal tissue factor, said animal having a genome in which cDNA encoding human TF has been...
|
|
|
7576259 |
Method for making genetic modifications
Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a...
|
|
|
7514592 |
Inducible heart attack animal model
An animal model of coronary heart disease has been developed where myocardial infarct can be induced by altering the animal's diet. In all embodiments, this animal model is a result of reduced...
|
|
|
7501554 |
Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene
The invention provides a transgenic animal producing low-lactose milk, which is transformed with a gene encoding an extracellular lactase-hydrolyzing enzyme cloned from a human small intestinal...
|
|
|
7498479 |
Animal model having a chimeric human liver
The present invention features a non-human animal model that is susceptible to infection by human hepatotrophic pathogens, particularly human hepatitis C virus (HCV). The model is based on a...
|
|
|
7491865 |
Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
Transgenic, non-human animal model of cancer, methods of making such animals and methods of using such animals to screen test compounds are provided.
|
|
|
7491868 |
Mannose binding lectin knock-out mice and methods of use thereof
A transgenic non-human animal with alterations in the MBL gene is prepared by introduction of a gene encoding an altered MBL protein into a host non-human animal. Methods for using transgenic mice...
|
|
|
7485769 |
Transgenic mammals
This invention provides a nonhuman transgenic mammal carrying transgene comprising the regulatory genes capable of functioning in the hyperacute rejection-occurring local cells and gene encoding...
|
|
|
7476536 |
Artificial human chromosome containing human antibody a light chain gene
The present invention relates to a human artificial chromosome which is genetically transmissible to the next generation with high efficiency and the method for using the same. More specifically,...
|
|
|
7420099 |
Transgenic animals and uses thereof
In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic...
|
|
|
7414170 |
Transgenic bovines capable of human antibody production
The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy...
|
|
|
7405342 |
Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor
The present invention is directed, at least in part, to mice which express exogenous complement receptor type 1 (CR1) on red blood cells. The invention also pertains to genetic constructs encoding...
|
|
|
7358416 |
Transgenic mouse expressing human FcRn protein
Disclosed is a transgenic knockout mouse whose genome comprises a homozygous disruption in its endogenous FcRn gene. The homozygous RcRn disruption prevents the expression of a functional FcRn...
|
|
|
7355095 |
Method for producing heart-specific fluorescence of non-human eukaryotic animals
A method of expressing in vivo heart-specific fluorescence in transgenic line of zebrafish is developed, which provides a research model for studying heart-related gene functions and performing...
|
|
|
7351875 |
FcγRIIa transgenic animal model for autoimmune disease
The present invention provides a FcγRIIa transgenic non-human animal model for autoimmune disease, particularly arthritis. This invention also provides a method of using this model to screen ...
|
|
|
7341871 |
Nucleotide sequences for gene regulation and methods of use thereof
The invention provides nucleic acid sequences which regulate expression of a nucleotide sequence of interest. In particular, the invention provides nucleic acid sequences which regulate expression...
|
|
|
7323618 |
Tissue specific expression of exogenous proteins in transgenic chickens
Transgenes encoding exogenous proteins are stably integrated into embryonic stem cells and are present in the somatic tissue of transgenic or chimeric birds. The transgenes encode exogenous...
|
|
|
7323616 |
Genetically altered mice deficient in functional caspase-9
The invention relates to genetically manipulated animals that are deficient in the expression of Caspase-9, a protein involved in programmed cell death. The invention further relates to methods for...
|
|
|
7309811 |
Transgenic mice knockouts of BACE-1
The invention provides transgenic animals that are heterozygous or homozygous for a nonfunctional allele of BACE-1. These animals show normal development indicating that BACE-1 is not necessary for...
|
|
|
7294754 |
Method for generating an animal homozygous for a genetic modification
Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a...
|
|
|
7282621 |
Somatic recombination
Recombination in mammalian somatic cell chromosomes is promoted and marked by a method called mosaic analysis with double marker (MADM). Mouse “knock-in” techniques are used to create pairs of chr...
|
|
|
7271311 |
Mammalian model for diabetes
An object of the present invention is to provide a model mammal for diabetes onset, being useful for elucidating the onset mechanism of diabetes caused by a blockage of signal transduction from...
|
|
|
7265259 |
GSK-3β expressed in a transgenic mouse
A transgenic animal in which GSK-3β protein is over-expressed is useful as a model for neurodegenerative disease.
|
|
|
7253334 |
Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
The invention provides methods for cloning mammals that allow the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte. The invention also features...
|
|
|
7250551 |
Transgenic mice expressing inducible human p25
Disclosed are improved methods of treating individuals with Alzheimer's disease (AD) as well as methods to diagnose AD in an individual. Also included are compounds and methods of identifying...
|